|Bid||119.18 x 800|
|Ask||119.50 x 800|
|Day's Range||118.90 - 121.03|
|52 Week Range||82.77 - 122.15|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||33.87|
|Earnings Date||Feb 17, 2020|
|Forward Dividend & Yield||2.16 (1.79%)|
|Ex-Dividend Date||Dec 25, 2019|
|1y Target Est||126.18|
With respect to Intersect ENT's (XENT) Propel line, the PROPEL suite scores as the standard of care for polyp patients undergoing sinus surgery.
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced that it received approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the safety and effectiveness of the PulseSelect™ Pulsed Field Ablation (PFA) System, a new technology that uses pulsed electric fields to treat atrial fibrillation. First procedures in the trial were performed in December 2019 by Bradley Wilsmore, M.D., at John Hunter Hospital, New Lambton Heights, NSW, Australia and in January by Atul Verma, M.D., the principal investigator (PI) for the study, at Southlake Regional Health Centre in Newmarket, Canada. PFA uses pulsed electric fields to ablate or create lesions and scar tissue to interrupt irregular electrical pathways in the heart and the triggers of atrial fibrillation.
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug delivery system, that will allow clinicians to more efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer pain and severe spasticity. Efficio management software allows clinicians to manage patients’ pumps with greater efficiency and ease by consolidating, organizing and providing visual summaries of patient data from the clinician programmer in a secure cloud environment accessible at anytime, anywhere.
Intel's board leadership is changing. Andy Bryant is stepping down after seven years as the board's chairman, and board members elected Medtronic CEO Omar Ishrak as his replacement on Jan. 15 along with new board member Alyssa Henry of Square. Intel went through big changes during Bryant's time as chairman, particularly in its data-centric businesses, PBJ reporter Malia Spencer explains.
Zimmer Biomet's (ZBH) execution of its priority agenda including quality remediation, supply recovery efforts and product introductions looks impressive.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceuticals ...
At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Reliefof at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1 DUBLIN, Jan. 21,.
For the first time in seven years, chip giant Intel Corp. has a new chairman of the board after Andy Bryant announced his departure last spring. At its Jan. 15 meeting, the board elected lead independent director Omar Ishrak chairman. Ishrak is the chairman and CEO of medical technology company Medtronic.
DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of Micra™ AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired. Medtronic now offers the first and only FDA-approved leadless pacemaker portfolio, expanding the number of potential candidates for this groundbreaking technology in the U.S.
DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) has been named to FORTUNE’s 2020 World’s Most Admired Companies List. “We are honored to be selected by Fortune for this prestigious recognition,” said Omar Ishrak, Medtronic chairman and chief executive officer.
Hill-Rom (HRC) is optimistic about its latest buyouts of Breathe Technologies and Voalte, mirroring its outstanding capital management strategy in turn.
IDEXX (IDXX) upgrades veterinary care experience by launching a rapid digital cytology service, thus enabling the provision of faster results.
Medtronic (MDT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Percentage of Americans aged 65 and above will climb to 21% by 2030 from 15% in 2018. In fact, the number of Americans aged more than 60 have already tripled since 1950.
Rating Action: Moody's affirms Cardinal Health's Baa2 senior unsecured rating; outlook changed to negative. Global Credit Research- 17 Jan 2020. New York, January 17, 2020-- Moody's Investors Service affirmed ...
Boston Scientific's (BSX) recent takeovers of BTG, NxThera, Claret Medical, VENITI and Augmenix make us optimistic about their positive synergies to be added to the company portfolio.
The FDA recently authorized diabetes care companies to start pairing their medical devices for diabetes management, by combining insulin pumps and glucose monitors.
Globus Medical (GMED) delivers solid spine sales globally. Enabling Technologies too rides high on the rising uptake of ExcelsiusGPS platform.